Ignite Creation Date:
2024-05-06 @ 2:13 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04253561
Status:
RECRUITING
Last Update Posted:
2023-04-18
First Post:
2020-01-17
Brief Title:
Ipatasertib Pertuzumab Trastuzumab in Advanced HER2 PI3KCA-mutant Breast Cancer Patients
Sponsor:
Organization:
SOLTI Breast Cancer Research Group